VAERS Explorer
Back to explore

Report #2842341

Received May 22, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
1 yrs
State
NJ
Recovered
Unknown
Vaccinated
Mar 31, 2025
Onset
Mar 31, 2025
Days to onset
0
Hospital days
—

Vaccines (4)

TypeNameManufacturerDoseLotRoute / Site
HIBVHIB (PEDVAXHIB)MERCK & CO. INC.3Y007178OT
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.1Y014440OT
PNC20PNEUMO (PREVNAR20)PFIZER\WYETH3—OT
UNKVACCINE NOT SPECIFIED (NO BRAND NAME)UNKNOWN MANUFACTURER1—OT

Symptoms (1)

Product storage error

Symptom narrative

No AE; vaccine storage issue; This spontaneous report was received from a nurse practitioner and refers to a 12-month-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 31-Mar-2025, the patient was vaccinated with the third dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB), (lot #Y007178, expiration date: 07-Nov-2026), the first dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y014440, expiration date: 22-Feb-2026) reconstituted with sterile diluent (MERCK STERILE DILUENT), (lot # and expiration date were not reported), the first dose of Hepatitis A vaccine) (lot# DN273, expiration date: 28-Aug-2026) and the third dose of Pneumococcal vaccine conj 20v (CRM197) (lot# LK6653, expiration date: 30-Jun-2026) all administered by intramuscular route for prophylaxis. On 09-Apr-2025, at compliance visit, upon review by state, temperature excursion was noted from 03-Mar-2025 to 10-Mar-2025 (product storage error). Upon further investigation and review by the DDL manufacturer, it was noted as a "glitch" "most likely caused by an electronical interference". The VFC program advised revaccination and that process was currently in progress with the patients involved. No adverse event was reported. This is one of several cases from the same reporter.; Sender's Comments: Priority : 5 , Is case serious : No , Index user :, Index date : 2025-05-14 , MNSC number : 02785949 , CLIC number : , ESTAR number : , IRMS number : , Central date : 2025-05-13 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number :

Other medications

Sterile diluent